CORONARY VENOUS SAMPLING via coronary sinus catheterization is now generally accepted as the method of choice for in vivo studies of arterial venous differences in the level of various metabolites in the human myocardium.1-5 Most previous studies using this approach have dealt with the output and/or uptake of products of carbohydrate metabolism (glucose, lactate, pyruvate ),6, 7-15 ammonia and amino acids,"' 16, 17 fatty acids, and triglycerides.6, 10, 1i, 13, 15, 16, 18 This paper reports data on ammonia metabolism i.n human myocardium, obtained by catheterization of the coronary sinus. The data suggest that ammonia metabolism in the human heart muscle is quite labile and may undergo significant changes in patients with heart disease.
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Methods
Thirty-two men, ages 35-58 years, were studied. Of these, 24 had ischemic heart disease as determined by case history, clinical observations, exercise testing, and cineangiography with selective coronary arteriography. In eight of the men other heart diseases (other myocardial disease and hypertension) were found.
Premedication included 1 ml of 2% promedole (4phenyl-4-propoxy-1,2,5-trimethyl-piperidine hydrochloride-an analgesic), 2 ml of 2.5% pipolphen (pen- [2- dimethyl aminopropyl]-phenothiazine hydrochloridean antihistamine and sedative), and 0.25 ml of 0.1% atropine, administered 1 hour prior to the beginning of each study. Novocaine was used for local anesthesia.
The catheterizations were performed in a fasting state at rest.
Blood samples were taken from the aorta and the coronary sinus. Three criteria were used to control the position of the catheter in the coronary sinus: (1) coronary arteriography data; (2) blood 02 saturation level; and (3) the pressure curve characteristic for coronary sinus. After sampling, the blood was allowed to stand for 1-1.5 hours at 360 and the clot was then separated by centrifugation. The serum was studied to determine its content of ninhydrin-positive compounds.
The method of study was as follows. Ten ml of 1% picric acid was added to 2 ml of serum, thoroughly mixed, and the denatured protein spun down by centrifugation at 4,000 rpm for 10 min. The supernatant (9 ml) was passed through a 0.9 x 8-cm column of Dowex 200-400 mesh in the C1form to remove any excess picric acid. Twenty ml of 0.2 N HCI and 10 ml of H20 were used sequentially for elution. Combined eluants were evaporated to dryness in vacuo at 400. Na-citrate buffer at pH 2.2 and analyzed by M121
The precipitate was dissolved in 3 ml of 0.2M Beckman amino acid analyzer, using standard technics. The analyses included data on the contents of urea, glutamine, glutamic acid, alanine, and ammonia in blood samples from the aorta and the coronary sinus. Concentrations of these compounds in blood were calculated assuming that no changes in coronary blood flow occurred during blood sampling.
Results
The data on urea, glutamine, glutamic acid, alanine, and NH3 content in blood from the aorta and the coronary sinus as well as calculated values for the uptake or output of these compounds after passage of blood through the myocardium (AC = sinus-aortic difference) are presented in table 1.
Analysis of the values for urea content in aortic and coronary sinus blood indicates that approximately half of the patients (cases 1-13) have an increase of urea in the coronary sinus blood with large variations in AC. No differences in urea Data on the Content of from Patients Examined CHAZOV ET AL. *The degree of confidence of the AC values was checked by testing the hypothesis that corresponding aortic and sinus values belonged to the same general population with known standard deviations and unknown mean values. Measurement errors were assumed to obey the law of normal distribution. Probability =P (x sinus > x) n [ 0.5o P )] was calculated wherep = XX ,p0o(y)= _ e-t2/2 dt, R = (x aorta+ x sinus)/2; n -2; is the average square deviation of the measurements. The AC V2r value was considered significant if P < 0.05. A C = Xsinus -Xaorta where Xsinus is the concentration of a substance in mg% in sinus blood, Xaor; is the analogous value in aortic blood. tThe AC value is not significant (P > 0.05).
values were found in patients 14-28, while a lower value of urea in coronary sinus blood as compared to aortic samples was observed in patients 28-32.
The glutamine content of coronary sinus blood in 19 patients was higher than in aortic blood. A reverse situation, i.e. a drop in glutamine values in coronary sinus blood was found in 11 patients. Two patients had no changes in the glutamine content of blood entering or leaving the heart.
In the case of alanine, 18 patients exhibited production of alanine by the myocardium, 11 cases showed uptake by the myocardium while three cases had no observable differences between aortic and sinus blood alanine levels.
Ammonia aortic/sinus ratios varied widely among the patients examined. There were no differences between aortic and sinus blood alanine levels in four patients, a decrease of ammonia in sinus blood in 10 patients, and production of ammonia by the myocardium in 18 patients.
In an effort to understand the relationships between "production" and/or "extraction" of metabolites by the myocardium correlation coefficients were calculated for all possible AC combinations. These data are presented in table 2. It is evident that absolute values of these coefficients are rather low. This may result from low linear dependence between AC of the substances under consideration but does not prove the absence of such dependence.
To further elucidate these relationships the same set of data were used to construct two correlation matrices: one for patients with positive AC for urea and another for patients with negative AC for the same substance. These matrices are presented in Circulation, Volume XLVII, June 1973 tables 3 and 4. (Calculation of correlation matrices, regression polynome coefficients, and plotting of graphs were carried out on HP 2116 C computer).
A comparison of the matrices in tables 3 and 4 with those in the general matrix (table 2) reveals that (1) there is an increase in the absolute values of the correlation coefficients; and (2) for these two groups of patients analogous coefficients are often of opposite signs. These results prompted us to look for nonlinear regression dependence between AC values. To this end the corresponding polynome coefficients were calculated and regression polynomes of the third degree plotted for several pairs of substances. These plots are shown in figures 1-9. An analysis of the curves in figures 1-9 indicates certain relationships between the AC's of nitrogenous metabolites: (1) There is no dependence between changes of any substance and the AC for 6 ); i.e. output of glutamine by the myocardium is accompanied by an uptake of glutamic acid from the passing blood; (4) changes in urea content parallel the AC's for alanine and glutamine (figs. 7, 8) .
Discussion
Although the amino acid analyzer permits the quantitative determination of 26 ninhydrin-positive compounds in blood, the results presented above deal only with five compounds, i.e. urea, glutamine, glutamic acid, alanine, and ammonia. This choice was made for the following reasons: (1) the concentration changes (AC) for these substances among the patients examined were most marked and; (2) all of these substances are directly related to the fate of ammonia produced in the myocardium during contraction.
The phenomenon of NH3 production during heart contractile work was originally demonstrated by Feinberg on rabbits. 19 It is likely that the NH3 formed in the myocardium is generated from the same sources as in skeletal muscle, i.e. deamination of adenylic acid and its derivatives; and catabolism of proteins, various amines and other nitrogenous compounds. Free ammonia is known to be cytotoxic and its elevation in tissue leads to a blockade of the Krebs cycle resulting in inhibition of glucose aerobic metabolism.20 A high level of free NH3 also has an inhibitory effect on protein synthesis.2' It is likely that the myocardium possesses a powerful mechanism to trap free ammonia in order to limit these effects on the tissues. Studies of ammonia metabolism in healthy human myocardium have demonstrated2' that at rest the myocardium extracts glutamic acid from the passing blood, and produces ammonia and glutamine. It is therefore reasonable to assume that in addition to the reactions of transamination in the human heart muscle, the mechanisms for NH3 binding include the formation of glutamic acid from a-ketoglutaric acid and ammonia as well as able 3 synthesis from glutamic acid and ammonia. However, it is not known whether NH3 binding in the human heart muscle may also occur through the formation of carbamyl-phosphate followed by transfer of NH3 into urea. In view of this uncertainty the most important fact found in this study is a strong suggestion of the existence of the urea cycle in human myocardium. This conclusion is based on the fact that in a number of patients the level of urea in coronary sinus blood was found to be significantly higher than in aortic blood. Although the urea cycle is known to exist not only in the liver but also in the kidneys22 and the brain23 data on urea formation in human myocardium are currently not available.
As is seen from table 1 some patients (cases 14-28) exhibit no differences between the levels of urea in aortic and sinus blood. One might therefore suppose that in healthy human myocardium the urea cycle, as a means of binding free ammonia, may be only slightly expressed. If so, the excess of coronary venous urea in some patients may be considered a compensatory shift of ammonia metabolism in response to a derangement of normal mechanisms of NH3 binding in the myocardium. In other words, it is suggested that the induction of the urea cycle may occur as an adaptive mechanism in the myocardium of certain patients with heart disease. This suggestion could be verified directly by studies of the tissue enzymes involved in the urea synthesis in healthy and diseased heart muscle. Preliminary determinations of arginase activity in human myocardial tissue removed at autopsy have indeed demonstrated the existence of this enzyme in the myocardium.
A detailed analysis of the data summarized in table 1 shows significant deviations in the uptake and output of nitrogenous substances as compared to previously determined values for normal human myocardiumt21 For instance, in some patients there was a complete reversal of glutamine and NH3 production by the myocardium. In other patients output rather than uptake of glutamic acid was found. It is therefore of interest to analyze the relationships between the changes of these compounds (AC) during the flow of blood through the myocardium. According to table 1, NH3 formed in the myocardium can be trapped and released into the circulation via the formation of urea, glutamine, alanine, and to a small degree as free ammonia. One might therefore expect some dependence between the production and/or uptake of these compounds by the myocardium and changes in the NH3 content in the passing blood. Relationships between AC for ammonia and alanine.
possible explanation for this lack of correlation might be that the changes in the NH3 level of blood leaving the myocardium are insignificant compared to the AC's for the other four nitrogenous compounds. Large changes in the NH3 level in the myocardium might be prevented by one or more mechanisms which keep it within certain strict limits.
What are the relationships between the substances which may be involved in NH3 removal from the myocardium? The most pronounced and evident relationship is found between alanine and glutamine ( fig. 5 ); a rise or fall in one of these amino acids is accompanied by similar changes of the second substance. One of the mechanisms underlying these relationships may be the formation of glutamine and alanine in reactions involving a common precursor (glutamic acid). It is known that in mammalian tissues glutamine is synthesized according to the glutamine synthetase reaction, and alanine by transamination of glutamic acid with pyruvate. The inverse relationship between glutamine and glutamic acid ( fig. 6 ) would argue for the formation of glutamine from glutamic acid in the heart muscle. On the other hand the dependence ( fig. 9 ) would argue against the formation of alanine by the reaction of glutamic acid with pyruvate since there is no inverse relationship between glutamic acid and alanine. Therefore it is unlikely that glutamic acid provides the amine nitrogen for alanine in the human myocardium.
It is of interest to compare figures 7 and 8 showing the relationships between three nitrogenous substances which may be involved in the removal of NH3 from the myocardium: urea, glutamine, and alanine. As mentioned earlier a linear relationship exists between the AC's for alanine and glutamine. Figures 7 and 8 clearly demonstrate that the relationships between the AC's for these substances and the production and/or uptake of urea in the same patients are very similar. This fact may be interpreted as an indication of a significant relationship between the formation of urea, glutamine, and alanine in the heart muscle. When AC for urea is close to zero the same holds for glutamine and alanine. A significant output of urea by the myocardium is coupled with an increase in the output of glutamine and alanine.
A similar increase is noticed in the case of urea "uptake" by the myocardium. If a simultaneous rise of urea, glutamine, and alanine in coronary venous blood may be interpreted as a shift of NHa myocardial metabolism caused by the necessity to bind excessive amounts of free ammonia formed in the tissues, then the phenomenon of glutamine and alanine production by the myocardium in patients where the "uptake" of urea was observed needs another explanation. Let us first consider the urea "uptake" by the myocardium found in some patients. It is difficult to believe that urea can be used anabolically, since AC Relationships between AC for alanine and glutamic acid. this would contradict existing views of nitrogenous metabolism in mammals. A more logical although speculative explanation of urea "uptake" by the myocardium would be deamination of urea in the heart muscle due to changes in the catalytic properties of some enzyme (or enzymes) which normally deaminate various amines and nucleotides. The possibility of urea deamination by structurally bound monoamine oxidase after treatment of rat liver mitochondria (or purified enzyme) by some oxidative agents has already been demonstrated by Gorkin et al.2426 Lipid peroxides which are thought to be important factors in the development of atherosclerosis27 may be likely candidates for natural oxidizers of this kind.
If the "uptake" of urea by the myocardium is indeed due to its deamination one can easily understand the left part of figures 7 and 8: the NH3 formed by urea deamination could then be bound and removed from the myocardium through the formation of glutamine and alanine.
In conclusion one may speculate that the changes AC GLUTAMINE, mg% Circulation, Volunme XLVII, June 1973 in NH3 metabolism found in patients suffering from heart disease may well represent the early and specific metabolic disturbances in the diseased myocardium. It is likely that a more thorough study of a larger number of patients would eventually make it possible to relate this type of metabolic imbalance to certain pathologic changes in the myocardium and specifically to the degree of coronary insufficiency.
